NONSURGICAL TREATMENT OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS

被引:75
作者
OHTO, M
YOSHIKAWA, M
SAISHO, H
EBARA, M
SUGIURA, N
机构
[1] First Department of Medicine, School of Medicine, Chiba University, Chiba, Inohana, Cyuo-ku
关键词
D O I
10.1007/BF00316978
中图分类号
R61 [外科手术学];
学科分类号
摘要
Modern imaging modalities have allowed us to make reliable diagnosis of hepatocellular carcinoma (HCC). Most of HCCs are associated with liver cirrhosis in varying stages of severity and often accompanied by new occurrences of HCC after treatment. Now, newly developed nonsurgical therapeutic modalities are used extensively and achieve good results in terms of anti-tumor effects as well as post-treatment survival.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
[31]   ARE ACUTE-PHASE PROTEINS A NEW BIOLOGICAL MARKER OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
PERNEY, P ;
PIVA, MT ;
SIESO, V ;
FABBROPERAY, P ;
COSTE, F ;
LEBRICQUIR, Y ;
HANSLIK, B ;
MION, H ;
BLANC, F .
HEPATOLOGY, 1995, 22 (04) :1469-1469
[32]   SMALL LIVER MASSES IN CIRRHOTIC-PATIENTS - A PATHOLOGICAL CLUE FOR THE MORPHOGENESIS OF HUMAN HEPATOCELLULAR-CARCINOMA [J].
GRIGIONI, WF ;
DERRICO, A ;
BACCI, F ;
CARELLA, R ;
MANCINI, AM .
ACTA PATHOLOGICA JAPONICA, 1989, 39 (08) :520-527
[33]   SEX-HORMONE IMBALANCE IN MALE ALCOHOLIC CIRRHOTIC-PATIENTS WITH AND WITHOUT HEPATOCELLULAR-CARCINOMA [J].
GUECHOT, J ;
PEIGNEY, N ;
BALLET, F ;
VAUBOURDOLLE, M ;
GIBOUDEAU, J ;
POUPON, R .
CANCER, 1988, 62 (04) :760-762
[34]   CAN HEPATIC-FAILURE AFTER SURGERY FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS BE PREVENTED [J].
TAKENAKA, K ;
KANEMATSU, T ;
FUKUZAWA, K ;
SUGIMACHI, K .
WORLD JOURNAL OF SURGERY, 1990, 14 (01) :123-127
[35]   TREATMENT OF SMALL HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS - A COHORT STUDY COMPARING SURGICAL RESECTION AND PERCUTANEOUS ETHANOL INJECTION [J].
CASTELLS, A ;
BRUIX, J ;
BRU, C ;
FUSTER, J ;
VILANA, R ;
NAVASA, M ;
AYUSO, C ;
BOIX, L ;
VISA, J ;
RODES, J .
HEPATOLOGY, 1993, 18 (05) :1121-1126
[36]   PROSPECTIVE-STUDY OF ALPHA-FETOPROTEIN IN CIRRHOTIC-PATIENTS MONITORED FOR DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA [J].
OKA, H ;
TAMORI, A ;
KUROKI, T ;
KOBAYASHI, K ;
YAMAMOTO, S .
HEPATOLOGY, 1994, 19 (01) :61-66
[37]   PROSPECTIVE-STUDY OF INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS AND ANALYSIS OF RISK-FACTORS [J].
BOLONDI, L ;
RIGAMONTI, A ;
SIRINGO, S ;
GAIANI, S ;
SOFIA, S ;
BONASERA, M ;
FUSCONI, F ;
BARBARA, C ;
BRILLANTI, S ;
CAVALLI, G ;
BARBARA, L .
HEPATOLOGY, 1992, 16 (04) :A168-A168
[38]   CHARACTERISTIC PHARMACODYNAMICS OF 1-HEXYCARBAMOYL-5-FLUOROURACIL METABOLISM IN CIRRHOTIC-PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
WATANABE, A ;
SHIOTA, T ;
HAYASHI, S ;
NAGASHIMA, H .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1984, 35 (04) :668-677
[39]   FOCAL ULTRASONOGRAPHIC LESION ON THE LIVER IN CIRRHOTIC-PATIENTS ALWAYS REFLECTS HEPATOCELLULAR-CARCINOMA - 217 CASES [J].
BUFFET, C ;
PRADES, P ;
HAGEGE, H ;
CAUQUIL, P ;
INK, O ;
ETIENNE, JP .
PRESSE MEDICALE, 1988, 17 (32) :1629-1632
[40]   ANTI-HCV ANTIBODY IN CHINESE CIRRHOTIC-PATIENTS WITH OR WITHOUT HEPATOCELLULAR-CARCINOMA - RELATION TO MULTITRANSFUSION [J].
CHANG, WY ;
WANG, LY ;
CHUANG, WL ;
CHEN, SC ;
LU, SN ;
YOU, SL .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1992, 7 (02) :128-131